Chimerism after paediatric stem cell transplantation

被引：0
|
作者：
Bilgen, H
Aydin, F
Ozdilli, K
Savran, F
Anak, S
Ozgenc, S
Carin, M
Gedikoglu, G
机构：
[1] Istanbul Univ, Istanbul, Turkey
[2] Golden Horn Univ, Istanbul, Turkey
[3] Our Children Leukemia Fdn, Istanbul, Turkey
[4] Med Fac Med Biol 1, Istanbul, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [41] Respiratory viruses after paediatric allogenic haematopoietic stem cell transplantation
    Ukonmaanaho, Elli-Maija
    Alexandersson, Adam
    Mannonen, Laura
    Lautenschlager, Irmeli
    Taskinen, Mervi
    Koskenvuo, Minna
    INFECTIOUS DISEASES, 2021, 53 (03) : 214 - 217
  • [42] Chimerism levels after stem cell transplantation are primarily determined by the ratio of donor to host stem cells
    Westerhuis, Geert
    van Pel, Melissa
    Toes, Rene E. M.
    Staal, Frank J. T.
    Fibbe, Willem E.
    BLOOD, 2011, 117 (16) : 4400 - +
  • [43] Profiling of Intestinal Microbiota of Paediatric Patients After Stem Cell Transplantation
    Lahteenmaki, Kaarina
    Wacklin, Pirjo
    Tuovinen, Elina
    Taskinen, Mervi
    Partanen, Jukka
    Vettenranta, Kim
    Matto, Jaana
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2014, 79 (06) : 453 - 453
  • [44] Increasing Chimerism after Allogeneic Stem Cell Transplantation Is Associated with Longer Survival Time
    Tang, Xiaowen
    Alatrash, Gheath
    Ning, Jing
    Jakher, Haroon
    Stafford, Patricia
    Zope, Madhushree
    Shpall, Elizabeth J.
    Jones, Roy B.
    Champlin, Richard E.
    Thall, Peter F.
    Andersson, Borje S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (08) : 1139 - 1144
  • [45] The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation
    Lion, T.
    Watzinger, F.
    Preuner, S.
    Kreyenberg, H.
    Tilanus, M.
    de Weger, R.
    van Loon, J.
    de Vries, L.
    Cave, H.
    Acquaviva, C.
    Lawler, M.
    Crampe, M.
    Serra, A.
    Saglio, B.
    Colnaghi, F.
    Biondi, A.
    van Dongen, J. J. M.
    van der Burg, M.
    Gonzalez, M.
    Alcoceba, M.
    Barbany, G.
    Hermanson, M.
    Roosnek, E.
    Steward, C.
    Harvey, J.
    Frommlet, F.
    Bader, P.
    LEUKEMIA, 2012, 26 (08) : 1821 - 1828
  • [46] Chimerism after allogeneic stem cell transplantation in patients with non-malignant disorders
    Svenberg, P.
    Mattsson, J.
    Ringden, O.
    Uzunel, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S175 - S175
  • [47] ALEMTUZUMAB AS THERAPY FOR MIXED CHIMERISM AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR FANCONI ANEMIA
    Chandra, Sharat
    Grimley, Michael
    Davies, Stella
    Myers, Kasiani
    Khandelwal, Pooja
    Zhang, Kejian
    Mehta, Parinda
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S12 - S12
  • [48] Influence of Mixed Chimerism on Outcome in Children With Anaemia After Haematopoietic Stem Cell Transplantation
    Lejman, Monika
    Zawitkowska, Joanna
    Zaucha-Prazmo, Agnieszka
    Cienkusz, Magdalena
    Mroczkowska, Aleksandra
    Kowalczyk, Jerzy
    Drabko, Katarzyna
    IN VIVO, 2019, 33 (06): : 2051 - 2057
  • [49] How and when should we monitor chimerism after allogeneic stem cell transplantation?
    Bader, P
    Niethammer, D
    Willasch, A
    Kreyenberg, H
    Klingebiel, T
    BONE MARROW TRANSPLANTATION, 2005, 35 (02) : 107 - 119
  • [50] Lineage-specific chimerism monitoring after allogeneic hematopoietic stem cell transplantation
    Caetano, J
    Martinho, A
    Freitas, A
    Paiva, A
    Silva, I
    Simöes, O
    Santos, P
    Campilho, F
    Campos, A
    Pimentel, P
    Regateiro, F
    BONE MARROW TRANSPLANTATION, 2003, 31 : S143 - S144
12345